Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8301107 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2013 | 13 Pages |
Abstract
Because alloalbumins do not seem to be associated with disease, they can be used as markers of migration and provide a model for study of neutral molecular evolution. They can also give valuable molecular information about albumins binding sites, antioxidant and enzymatic properties, as well as stability. Mutants with increased affinity for endogenous or exogenous ligands could be therapeutically relevant as antidotes, both for in vivo and extracorporeal treatment. Variants with modified biodistribution could be used for drug targeting. In most cases, the desired function can be further elaborated by producing site-directed, recombinant mutants. This article is part of a Special Issue entitled Serum Albumin.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Ulrich Kragh-Hansen, Lorenzo Minchiotti, Monica Galliano, Theodore Jr.,